Covington Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $10.5M | Buy |
239,102
+5,784
| +2% | +$281K | 0.45% | 70 |
|
|
2022
Q2 | $12.2M | Buy |
233,318
+92,732
| +66% | +$4.73M | 0.5% | 62 |
|
|
2022
Q1 | $7.28M | Buy |
140,586
+694
| +0.5% | +$36K | 0.26% | 106 |
|
|
2021
Q4 | $8.26M | Buy |
139,892
+2,577
| +2% | +$128K | 0.29% | 96 |
|
|
2021
Q3 | $5.91M | Buy |
137,315
+15,337
| +13% | +$679K | 0.22% | 118 |
|
|
2021
Q2 | $4.78M | Buy |
121,978
+6,625
| +6% | +$258K | 0.19% | 129 |
|
|
2021
Q1 | $4.18M | Buy |
115,353
+16,221
| +16% | +$576K | 0.18% | 129 |
|
|
2020
Q4 | $3.65M | Sell |
99,132
-8,498
| -8% | -$312K | 0.16% | 131 |
|
|
2020
Q3 | $3.75M | Sell |
107,630
-6,217
| -5% | -$218K | 0.19% | 125 |
|
|
2020
Q2 | $3.53M | Buy |
113,847
+544
| +0.5% | +$18.5K | 0.2% | 123 |
|
|
2020
Q1 | $3.51M | Buy |
113,303
+487
| +0.4% | +$16.6K | 0.23% | 111 |
|
|
2019
Q4 | $4.19M | Sell |
112,816
-2,863
| -2% | -$102K | 0.22% | 116 |
|
|
2019
Q3 | $3.94M | Sell |
115,679
-6,965
| -6% | -$253K | 0.23% | 113 |
|
|
2019
Q2 | $5.04M | Sell |
122,644
-70
| -0.1% | -$2.78K | 0.3% | 94 |
|
|
2019
Q1 | $4.95M | Sell |
122,714
-4,954
| -4% | -$198K | 0.31% | 94 |
|
|
2018
Q4 | $5.29M | Sell |
127,668
-1,179
| -0.9% | -$48.9K | 0.37% | 84 |
|
|
2018
Q3 | $5.39M | Sell |
128,847
-28,343
| -18% | -$1.09M | 0.33% | 85 |
|
|
2018
Q2 | $5.41M | Sell |
157,190
-3,472
| -2% | -$119K | 0.35% | 82 |
|
|
2018
Q1 | $5.41M | Sell |
160,662
-17,446
| -10% | -$600K | 0.36% | 83 |
|
|
2017
Q4 | $6.12M | Buy |
178,108
+2,441
| +1% | +$83.2K | 0.38% | 78 |
|
|
2017
Q3 | $5.95M | Buy |
175,667
+8,903
| +5% | +$286K | 0.39% | 79 |
|
|
2017
Q2 | $5.32M | Sell |
166,764
-2,213
| -1% | -$69.8K | 0.43% | 76 |
|
|
2017
Q1 | $5.49M | Sell |
168,977
-7,536
| -4% | -$238K | 0.46% | 74 |
|
|
2016
Q4 | $5.44M | Sell |
176,513
-2,873
| -2% | -$87.7K | 0.48% | 75 |
|
|
2016
Q3 | $5.76M | Buy |
179,386
+4,655
| +3% | +$156K | 0.53% | 70 |
|
|
2016
Q2 | $5.84M | Sell |
174,731
-2,296
| -1% | -$73.3K | 0.54% | 73 |
|
|
2016
Q1 | $4.98M | Buy |
177,027
+18,845
| +12% | +$538K | 0.48% | 76 |
|
|
2015
Q4 | $4.84M | Sell |
158,182
-2,838
| -2% | -$89.3K | 0.47% | 78 |
|
|
2015
Q3 | $4.8M | Sell |
161,020
-175,729
| -52% | -$5.63M | 0.5% | 72 |
|
|
2015
Q2 | $10.7M | Sell |
336,749
-2,828
| -0.8% | -$92.2K | 0.96% | 34 |
|
|
2015
Q1 | $11.2M | Sell |
339,577
-19,044
| -5% | -$605K | 1.08% | 27 |
|
|
2014
Q4 | $10.6M | Sell |
358,621
-193,639
| -35% | -$5.55M | 0.94% | 30 |
|
|
2014
Q3 | $15.5M | Buy |
552,260
+3,747
| +0.7% | +$105K | 1.42% | 12 |
|
|
2014
Q2 | $15.9M | Sell |
548,513
-3,145
| -0.6% | -$89.7K | 1.44% | 10 |
|
|
2014
Q1 | $16.8M | Buy |
551,658
+1,528
| +0.3% | +$45.6K | 1.64% | 6 |
|
|
2013
Q4 | $16M | Sell |
550,130
-7,846
| -1% | -$228K | 1.63% | 7 |
|
|
2013
Q3 | $15.2M | Sell |
557,976
-128
| -0% | -$3.48K | 1.74% | 7 |
|
|
2013
Q2 | $14.8M | Buy |
+558,104
| New | +$15.4M | 1.82% | 6 |
|
Other funds holding PFE
Covington Capital Management's PFE Position: Q3 2022 in Review
Covington Capital Management increased its Pfizer (PFE) stake by 2.5% in Q3 2022, buying an estimated $281K and bringing the position to 239,102 shares worth $10.5M. The position accounts for 0.45% of the portfolio, ranked #70.
Covington Capital Management first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $16.8M in Q1 2014. 3,086 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Covington Capital Management held 239,102 shares of Pfizer worth $10.5M as of Q3 2022.
- Covington Capital Management bought 5,784 Pfizer shares in Q3 2022, an estimated $281K.
- Pfizer made up 0.45% of Covington Capital Management's portfolio in Q3 2022, its #70 holding.
- Covington Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
- Covington Capital Management's Pfizer position peaked at $16.8M in Q1 2014.
- 3,086 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.